Abivax (ABVX) Non Operating Income (2024 - 2026)

Abivax's Non Operating Income history runs 3 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 271.99% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at -$82.9 million (down 652.43% YoY), while the FY2025 annual figure was -$98.0 million, down 2715.18% from the prior year.
• Non Operating Income was $9.4 million for Q1 2026 at Abivax, up from -$5.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $9.4 million in Q1 2026 to a low of -$84.9 million in Q3 2025.
• Historically, Non Operating Income has averaged -$10.2 million across 3 years, with a median of -$3.7 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Non Operating Income plunged 1435.29% in 2025, then surged 271.99% in 2026.
• A 3-year view of Non Operating Income shows it stood at $3.7 million in 2024, then slumped by 242.11% to -$5.2 million in 2025, then surged by 280.04% to $9.4 million in 2026.
• The last three Non Operating Income figures came in at $9.4 million (Q1 2026), -$5.2 million (Q4 2025), and -$84.9 million (Q3 2025), per Business Quant data.